Insmed Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF93.37 | Buy/Sell | CHF105.00 | 15.26% | 9 | CHF190.51B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$67.72 | Buy/Sell | $87.82 | 18.13% | 14 | $84.36B |
| ALKS | Alkermes | Outperform |
10
|
$24.15 | Buy/Sell | $33.27 | 32.51% | 3 | $4.11B |
| ASRT | Assertio Holdings | Buy |
8
|
$1.07 | Buy/Sell | $3.50 | 180.37% | 2 | $100.36M |